New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Lytmus Unveils Standalone, Pair-Programing Phone Screen Solution to Ensure Companies Hire the Best and Candidates Get a Real Job Preview
-
BloomReach Raises $56 Million To Personalize The Web
-
Vito Palombella, PhD Joins Surface Oncology as Chief Scientific Officer
-
Branch Metrics Raises $35 Million as it Becomes the Mobile Industry Standard for Deep Linking with Over 1 Billion Users and 1.6 Billion Links Created
-
Tarveda Therapeutics Appoints Oncology Drug Development Leader Leila Alland, M.D., as Chief Medical Officer
-
Blend Therapeutics Secures $38 Million in Series C Financing led by Novo A/S and NEA and Changes Name to Tarveda Therapeutics
-
Form SC 13D/A ARDELYX, INC. Filed by: New Enterprise Associates 12, Limited Partnership
-
Form SC 13D/A Epizyme, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Penske Media Acquires Indiewire
-
vXchnge to offer Direct Access to Console in 6 U.S. Markets
-
Luminal raises $20M for its cloud operating system, changes name to Fugue
-
Form 4 ARDELYX, INC. For: Jan 13 Filed by: New Enterprise Associates 12, Limited Partnership
-
Healthcare IT VC Funding in 2015 Plateaus at $4.6 Billion, Reports Mercom Capital Group
-
Cybersecurity Deception Technology Pioneer illusive networks Hires First Channel Chief to Launch 100% Channel Sales Strategy
-
VeloCloud Raises $27M to Meet Growing Global Demand for SD-WAN
-
Form 4 Epizyme, Inc. For: Jan 12 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
New venture aims to fill customer-service void in healthcare
-
Heartware (HTWR) Sees Q4 Revenue of $68M
-
HeartWare International Provides Corporate Updates And Announces Preliminary Revenue For Fourth Quarter 2015
-
Heartware (HTWR) Prelim. Q4 Revenue Flat with Expectations; Offers Corp. Update
-
HeartWare Expands Board Of Directors With Appointment Of Stephen N. Oesterle, M.D.
-
Care.com and Stride Health Team up to Provide Caregivers Access to Quality Benefits
-
Form SC 13D/A SUNESIS PHARMACEUTICALS Filed by: New Enterprise Associates 12, Limited Partnership
-
ESSA Pharma (EPIX) CEO Rieder Resigns; Successor Appointed
-
ESSA Pharma Announces Senior Leadership Changes
-
Vtesse, Inc. Announces FDA's Granting of Breakthrough Therapy Designation for VTS-270 in Niemann-Pick Type C1 Disease
-
Synlogic to Present at the 34th Annual J.P. Morgan Healthcare Conference
-
Millendo Licenses Phase 2 Polycystic Ovary Syndrome (PCOS) Drug Candidate from AstraZeneca and Secures Series B Financing of $62 Million to Advance Pipeline of Endocrine Disorder Therapies
-
PsiKick Raises $16.5M Series B Round to Power a Batteryless Revolution in the “Internet of Things”
-
Form SC 13D/A TREVENA INC Filed by: New Enterprise Associates 12, Limited Partnership
-
Lytmus Reveals the Top U.S. States for Skilled Emerging Computer Coding Talent -- and It's Not Where You Think
-
Sonatype Is First to Market With A Free Universal Repository Manager to Include Support for Docker Images and npm JavaScript Modules
-
Intuit and Stride Health Help the Self-Employed Meet December 15th Open Enrollment Deadline
-
DC Inno Announces the Winners of the 3rd Annual 50 on Fire Awards
-
Form SC 13D/A SUPERNUS PHARMACEUTICALS Filed by: NEW ENTERPRISE ASSOCIATES 11 LP
-
Eargo Raises $25M in Series B Funding From New Enterprise Associates
-
Swift Navigation Raises $11 Million Series-A Round for Next Generation High-Accuracy GPS for Autonomous Vehicles
-
Ziegler Advises Radiology Associates of Canton and RadHelp on their Partnership with Radiology Partners
-
New Enterprise Associates to Distribute 3.8M Shares of Supernus Pharmaceuticals (SUPN)
-
Supernus Pharmaceuticals (SUPN) Announces Distribution from NEA
-
Supernus Announces Distribution of Common Stock by NEA
-
Supernus Announces Distribution of Common Stock by NEA
-
Adaptimmune Wins Scrip Award for Financing Deal of the Year
-
Adaptimmune Wins Scrip Award for Financing Deal of the Year
-
ThreatQuotient Raises $10.2M in Series A Funding Led by New Enterprise Associates, Appoints John Czupak as CEO
-
First Republic Bank Launches Financial Literacy Initiative For Elementary School Students
-
Form SC 13D XTERA COMMUNICATIONS, Filed by: NEW ENTERPRISE ASSOCIATES 9 L P
-
Form SC 13D/A SUPERNUS PHARMACEUTICALS Filed by: NEW ENTERPRISE ASSOCIATES 11 LP
-
Placester Raises $27 Million in Series C Funding
-
ObsEva Closes CHF 60 (USD 60) Million in Series B Financing

